The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …

Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …

Despite significant research progress in substantiating the therapeutic merits of
nanomedicines and the emergence of sophisticated nanotechnologies, the translation of this …

With the development of nanotechnology and confronting the problems of traditional
pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have …

Introduction Dry powder inhaler (DPI) formulations are gaining attention as universal
formulations with applications in a diverse range of drug formulations. The practical …

The supercritical antisolvent-fluidized bed coating process (SAS-FB) shows great potential
as a technique to manufacture dry powder inhaler (DPI) that incorporate nanodrugs onto …

In the last decade, nanocarriers have been widely used to target specific organs and
disorders of any kind. Nonetheless, the commercialization of nanocarriers for many …

Background Pulmonary drug delivery is an efficient way to deliver drugs directly to the site of
action ie, lungs or to the blood circulation with minimum systemic effects. Recent emergence …

Nanomedicine becomes a key player especially as next generation medicine. Antibody-
conjugated nanomedicine could significantly upgrade the treatment and expand application …

Lung cancer is a leading cause of global cancer mortality, often treated with
chemotherapeutic agents. However, conventional approaches such as oral or intravenous …